Business
Notice convening the annual general meeting in Pharma Equity Group A/S
25 March 2026 Announcement no. 4 Notice convening the annual general meeting in Pharma Equity Group A/S The board of directors hereby convenes the annual general meeting in Pharma Equity Group A/S (“PEG” or the “Company”) to be held on: 16 April 2026, at 3.30 PM CEST at Wihlborgs CanteensSlotsmarken 15DK-2970 Hørsholm The agenda for the annual general meeting is as follows: The board of directors' report on the Company's activities in the past yearPresentation of the audited annual report for ap
About this update from Pharma Equity Group A/s Class A
[{"type":"image","alt":"Pharma Equity Group A/S","displaySize":"","headline":null,"caption":"Pharma Equity Group A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":34,"url":"https://media.zenfs.com/en/globenewswire.com/83879c7411aab943b7350e2e06a6fb7c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jPpWLNKdrqa99i9B0sGpWw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQ4/https://media.zenfs.com/en/globenewswire.com/83879c7411aab943b7350e2e06a6fb7c","width":300,"height":34}},"lazy":false},{"type":"text","content":"25 March 2026","length":13,"tagName":"p"},{"type":"text","content":"Announcement no. 4","length":18,"tagName":"p"},{"type":"text","content":"Notice convening the annual general meeting in Pharma Equity Group A/S","length":70,"tagName":"p"},{"type":"text","content":"The board of directors hereby convenes the annual general meeting in Pharma Equity Group A/S (“PEG” or the “Company”) to be held on:","length":132,"tagName":"p"},{"type":"text","content":"16 April 2026, at 3.30 PM CEST","length":30,"tagName":"p"},{"type":"text","content":"at","length":2,"tagName":"p"},{"type":"text","content":"Wihlborgs CanteensSlotsmarken 15DK-2970 Hørsholm","length":50,"tagName":"p"},{"type":"text","content":"The agenda for the annual general meeting is as follows:","length":56,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The board of directors' report on the Company's activities in the past year","length":83,"tagName":"p"}]},{"val":[{"type":"text","content":"Presentation of the audited annual report for approval","length":54,"tagName":"p"}]},{"val":[{"type":"text","content":"Discharge to the board of directors and the executive board from liability","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Adoption of appropriation of profit or loss as proposed by the board of directors","length":81,"tagName":"p"}]},{"val":[{"type":"text","content":"Presentation of the remuneration report 2025 for an advisory vote","length":65,"tagName":"p"}]},{"val":[{"type":"text","content":"Approval of remuneration to the board of directors for the current financial year","length":81,"tagName":"p"}]},{"val":[{"type":"text","content":"Election of the board of directors","length":34,"tagName":"p"}]},{"val":[{"type":"text","content":"Election of auditor","length":19,"tagName":"p"}]},{"val":[{"type":"text","cont...